Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous caffeine versus intravenous ketorolac for migraine headache
IRCT2013120315640N1Phase 3Completed
- Sponsor
- Shohadaye Tajrish Clinical Research Development Center
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of caffeine and ketorolac in migraine (2 arms), sponsored by Shohadaye Tajrish Clinical Research Development Center. Started Dec 2013; status: completed.
02
Drugs
caffeineketorolac
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT2013120315640N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2013120315640N1.